Production and market comparison of urokinase and streptokinase as effective and cheap fibrinolytic agents for treatment of cardiovascular diseases

Failure of hemostasis and the formation blood clots in arteries are main reasons that provoke onset cardiovascular diseases (CVDs) such as myocardial infarction ischemic stroke. Cardiovascular have become primary cause deaths disabilities across globe. Therefore, this problem needs to be addressed with urgency. The disintegration requires fibrinolytic agents, which involved thrombolysis. Streptokinase urokinase enzymes; former is primarily produced from microbial sources latter isolated urine, respectively. been use for a long time treat diseases. This review explains detail comparison employing streptokinase said purpose cost-effective manner. recombinant production both agents has discussed detail. Furthermore, efficacy compared based upon their side effects retention body. A thorough study made compare influence using on health patients last decade.